Nurse Anesthetist - CR in Stratford, CT Accepting Medicare

2 Nurse Anesthetist - CR nurses found. Showing 1 - 2

Meghan Leary, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 7365 Main St, Suite 310, Stratford, CT 06614 Phone: 800-586-2153

Ms. Carrie R Jordan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 7365 Main St Ste 310, Stratford, CT 06614 Phone: 203-384-3174    Fax: 203-384-4619

News Archive

Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

Gov't health IT spending attracts investments from all over

As part of its foray into health IT, AT&T has partnered with WellDoc, a Baltimore-based company that makes an FDA-approved mobile-phone application to help manage diabetes, The Baltimore Sun reports. "The telecommunications giant launched a new business segment last week that will focus on technology solutions for the health care industry. And WellDoc's software will be pitched by AT&T's huge marketing muscle to commercial clients ranging from hospitals to insurers to employers" (Sentementes, 11/8).

APR launches new Corporate Website, changes Business Model

APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.

Chemotherapy combination outcomes differ for aged, younger colon cancer patients

The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 - but not for those who are older, according to Mayo Clinic and Dana-Farber Cancer Institute scientists who will present their findings at the American Society of Clinical Oncology's (ASCO) annual meeting in Orlando, Fla.

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.

Read more Medical News

› Verified 7 days ago